Showing results (1841-1850 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|May 27, 2021
Real-world pharmacokinetics and pharmacodynamics of everolimus in metastatic breast cancerMasahide Fukudo, Kei Ishibashi, Masahiro KitadaInvestigational New Drugs|June 23, 2021
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 studyYoichi Naito, Yasutoshi Kuboki, Masafumi Ikeda, et al.Investigational New Drugs|January 12, 2023
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinomaHiroya Manaka, Satoshi Igawa, Michiko Yamamoto, et al.Investigational New Drugs|December 20, 2022
A phase 1 study of intravenous mitazalimab, a CD40 agonistic monoclonal antibody, in patients with advanced solid tumorsVictor Moreno, Ruth Perets, Tamar Peretz-Yablonski, et al.Investigational New Drugs|January 1, 1987
Comparison of cancer chemotherapeutic agents in asynchronous and synchronous 9L cellsS D Henderson, B F Kimler, M L BarnesInvestigational New Drugs|January 1, 1987
Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (a phase II trial of the gynecologic oncology group)H B Muss, B N Bundy, H D Homesley, et al.Investigational New Drugs|June 8, 2022
ZL-n-91, a specific Phosphodiesterase-4 inhibitor, suppresses the growth of triple-negative breast cancerLongming Liang, Hansi Chen, Ping Mao, et al.Investigational New Drugs|July 8, 2022
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumorsFilip Janku, Seung-Hoon Beom, Yong Wha Moon, et al.Investigational New Drugs|November 28, 2022
An open label phase II study of safety and clinical activity of naltrexone for treatment of hormone refractory metastatic breast cancerJayanthi Vijayakumar, Tufia Haddad, Kalpna Gupta, et al.Investigational New Drugs|November 28, 2022
Pharmacokinetics and bioequivalence of two pomalidomide capsules in healthy chinese subjects under fasting and fed conditionsZhengzhi Liu, Zhongnan Xu, Zhenyue Gao, et al.Pageof 372